DCGI

Rajeev Raghuvanshi appointed head of apex drug regulatory panel

Current Secretary-cum-Scientific Director at Indian Pharmacopoeia Commission, has been given the DCGI charge for a three-year period ending on February 28, 2025

DCGI serves a show cause notice to 20 e-pharmacy companies

According to the DGCI, despite the apex regulator's directives to comply with the Delhi High Court's ruling, e-pharmacies were found to be selling medications online without a licence.

Government extends tenure of DCGI chief VG Somani by three months

The tenure of Venugopal Somani as the head of the Drugs Controller General of India (DCGI) has been extended by three months.

DGCI permits Serum Institute of India to manufacture vaccines against Omicron

SII has received permission and licences to produce SARS-CoV-2rS drug substances for research, test and analysis.

Biological E gets DCGI approval to conduct phase 2/3 trials on kids

DCGI gives approval to Cipla to import Moderna’s COVID-19 vaccine for emergency use

Serum Institute applies to DCGI to Manufacture Sputnik V Vaccine

The Serum Institute has applied to the DCGI seeking permission to manufacture Russia's COVID Vaccine Sputnik V in the country.

DCGI aprroves use of Zydus’s Virafin in treating moderate COVID-19 infection

Zydus Cadila has received emergency use approval from the Drugs Controller General of India (DCGI) on Friday in treating moderate COVID-19 infection.

Zydus Cadila receives DCGI nod for Phase-I trial of ZYIL1